Prior to project kick-off our pharmacovigilance team will review all available safety information and will create a well-informed risk-balanced plan in preparation of receiving reports from investigators globally. Matters related to safety is of paramount importance to us; therefore, meaningful metrics will feature in our customer dashboards.
At Axcellant we do not have barriers to communication, your study will have a key point of contact for each key discipline. Our Project Managers will have both the ‘telescopic’ and ‘microscopic view of your study.
Axcellant is excited to announce our participation at the European Association of Nuclear Medicine (EANM) Congress in Hamburg from October…
Marking a significant achievement in our ongoing efforts to advance medical device research, we have successfully concluded a PMCF study…
Initiating a clinical trial is akin to embarking on a voyage of discovery in the realm of medicine. This journey,…
Copyright @ 2025 Axcellant. Designed By Frantic